Heat Biologics, which recently filed for a $30-plus million IPO to continue funding its treatments for non-small cell lung cancer and bladder cancer, was recruited to Chapel Hill from Miami by NCBiotech, which also gave the clinical-stage company a $250,000 Strategic Growth Loan in 2012. (photo: Heat Biologics)
The Impact of Biotech
For more than 25 years, they have strengthened the state’s life science research base. More than $60 million in research grants to colleges, universities and nonprofit institutions across the state helped leverage significant outside funding for these institutions.